Natera, Inc.

Healthcare · Diagnostics & Research · United States

Last price 410.38 USD (Oct 30, 2026, 3:12 PM EDT) · Market cap 59.15B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizo...